FDA Recall of Medtronic MiniMed 530G Insulin Pump
Areazine synthesizes this FDA recall directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.
Medtronic MiniMed, Inc. is recalling 13,429 units of the MiniMed 530G Insulin Pump due to potential unintended over- and under-delivery of insulin caused by gravitational forces.
What this FDA recall tells you, and what most readers miss
This notice was issued by FDA on April 15, 2026 and geographically references United States and Worldwide. Its severity classification of "high" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - FDA Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are recall, product-safety, fda, Devices.
FDA Recall of Medtronic MiniMed 530G Insulin Pump
What Happened
Medtronic MiniMed, Inc. initiated a recall because their infusion pumps, including the MiniMed 530G, can experience unintended over- and under-delivery of insulin due to changes in gravitational force affecting pressures, which may lead to severe health risks.
Which Products Are Affected
The affected products are the MiniMed 530G Insulin Pump with model numbers MMT-551 and MMT-751. A total of 13,429 units are involved. The distribution includes US nationwide across states such as OR, CA, AZ, NY, TX, FL, OH, MO, TN, NJ, NC, SC, IL, VA, WA, DC, GA, PA, MS, IA, MI, NH, OK, SD, MT, WI, WV, MA, LA, MN, RI, AR, ME, AL, IN, UT, KY, CO, ND, MD, CT, NM, KS, ID, NV, DE, NE, VT, AK, HI, WY, PR, VI, and worldwide to countries including Taiwan, Australia, Canada, and many others. The recall number is Z-1751-2026, with code information including UDI-DI (GTIN) numbers like 00643169507784.
What You Should Do
Consumers who received an initial notification letter from the firm should follow the instructions provided in that letter regarding the recall.
Why This Matters
This recall is significant because the potential for insulin over- or under-delivery could result in severe health issues, including hypoglycemia or hyperglycemia that may lead to serious complications or death, affecting users who rely on these devices for diabetes management.
Source
Attribution: FDA recall notice with event ID 98186, available through the FDA's database.
Original source: FDA Official Notice ↗
Related FDA Recalls
All FDA Recalls →Nationwide notices with similar length or severity timing 8
Two Areazine-derived peer sets for this FDA recall: nearest notices by body length and by same severity near the same agency date. Peers come from other categories so they are not the same-feed Related list above.
Similar body length
Nearest notices by article body length (1,529 characters here).
Similar severity timing
Same severity (high) notices issued closest in time to April 15, 2026.
Frequently Asked Questions
Common questions about this FDA recall.